Morena Sangiovanni

Boehringer Ingelheim Italia SpA engages in the research and development of pharmaceutical drugs for cardiovascular, respiratory and virological diseases. It operates through the following business divisions: prescription and hospital drugs; products for self-medication and well-being; and veterinary medicine. The company was founded in 1972 and is headquartered in Milan, Italy.

Boehringer Ingelheim Italia SpA engages in the research and development of pharmaceutical drugs for cardiovascular, respiratory and virological diseases. It operates through the following business divisions: prescription and hospital drugs; products for self-medication and well-being; and veterinary medicine. The company was founded in 1972 and is headquartered in Milan, Italy.

Boehringer Ingelheim Italia SpA engages in the research and development of pharmaceutical drugs for cardiovascular, respiratory and virological diseases. It operates through the following business divisions: prescription and hospital drugs; products for self-medication and well-being; and veterinary medicine. The company was founded in 1972 and is headquartered in Milan, Italy.

Boehringer Ingelheim Italia SpA engages in the research and development of pharmaceutical drugs for cardiovascular, respiratory and virological diseases. It operates through the following business divisions: prescription and hospital drugs; products for self-medication and well-being; and veterinary medicine. The company was founded in 1972 and is headquartered in Milan, Italy.